De Burlo Group’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $587K | Sell |
4,667
-50
| -1% | -$6.28K | 0.08% | 65 |
|
|
2025
Q1 | $522K | Buy |
4,717
+100
| +2% | +$11.1K | 0.08% | 66 |
|
|
2024
Q4 | $630K | Sell |
4,617
-500
| -10% | -$68.3K | 0.08% | 64 |
|
|
2024
Q3 | $590K | Hold |
5,117
| – | – | 0.07% | 66 |
|
|
2024
Q2 | $704K | Sell |
5,117
-50
| -1% | -$6.88K | 0.09% | 62 |
|
|
2024
Q1 | $713K | Sell |
5,167
-4,000
| -44% | -$552K | 0.09% | 65 |
|
|
2023
Q4 | $1.03M | Hold |
9,167
| – | – | 0.18% | 56 |
|
|
2023
Q3 | $1.03M | Hold |
9,167
| – | – | 0.18% | 56 |
|
|
2023
Q2 | $864K | Hold |
9,167
| – | – | 0.14% | 66 |
|
|
2023
Q1 | $928K | Hold |
9,167
| – | – | 0.18% | 66 |
|
|
2022
Q4 | $1.09M | Hold |
9,167
| – | – | 0.24% | 56 |
|
|
2022
Q3 | $974K | Buy |
+9,167
| New | +$974K | 0.23% | 54 |
|
|
2022
Q2 | – | Sell |
-9,333
| Closed | -$875K | – | 160 |
|
|
2022
Q1 | $875K | Sell |
9,333
-1,450
| -13% | -$136K | 0.16% | 62 |
|
|
2021
Q4 | $918K | Sell |
10,783
-700
| -6% | -$59.6K | 0.13% | 74 |
|
|
2021
Q3 | $1.1M | Hold |
11,483
| – | – | 0.18% | 67 |
|
|
2021
Q2 | $1.12M | Hold |
11,483
| – | – | 0.18% | 62 |
|
|
2021
Q1 | $1.12M | Sell |
11,483
-100
| -0.9% | -$9.73K | 0.2% | 61 |
|
|
2020
Q4 | $1.11M | Sell |
11,583
-300
| -3% | -$28.7K | 0.18% | 59 |
|
|
2020
Q3 | $1.14M | Buy |
11,883
+133
| +1% | +$12.8K | 0.21% | 59 |
|
|
2020
Q2 | $1.02M | Hold |
11,750
| – | – | 0.29% | 42 |
|
|
2020
Q1 | $1.02M | Sell |
11,750
-300
| -2% | -$26K | 0.29% | 42 |
|
|
2019
Q4 | $1.3M | Sell |
12,050
-300
| -2% | -$32.2K | 0.26% | 56 |
|
|
2019
Q3 | $1.11M | Hold |
12,350
| – | – | 0.25% | 54 |
|
|
2019
Q2 | $1.04M | Sell |
12,350
-300
| -2% | -$25.3K | 0.2% | 59 |
|
|
2019
Q1 | $1.11M | Sell |
12,650
-3,650
| -22% | -$321K | 0.22% | 67 |
|
|
2018
Q4 | $1.16M | Sell |
16,300
-600
| -4% | -$42.8K | 0.26% | 61 |
|
|
2018
Q3 | $2.08M | Hold |
16,900
| – | – | 0.39% | 68 |
|
|
2018
Q2 | $1.66M | Hold |
16,900
| – | – | 0.35% | 65 |
|
|
2018
Q1 | $1.4M | Hold |
16,900
| – | – | 0.31% | 64 |
|
|
2017
Q4 | $1.31M | Sell |
16,900
-800
| -5% | -$62.1K | 0.27% | 68 |
|
|
2017
Q3 | $1.08M | Sell |
17,700
-4,650
| -21% | -$285K | 0.24% | 68 |
|
|
2017
Q2 | $1.03M | Sell |
22,350
-5,300
| -19% | -$244K | 0.23% | 71 |
|
|
2017
Q1 | $1.2M | Sell |
27,650
-23,800
| -46% | -$1.03M | 0.26% | 64 |
|
|
2016
Q4 | $1.99M | Sell |
51,450
-1,000
| -2% | -$38.7K | 0.48% | 55 |
|
|
2016
Q3 | $2.66M | Hold |
52,450
| – | – | 0.74% | 55 |
|
|
2016
Q2 | $2.38M | Hold |
52,450
| – | – | 0.58% | 57 |
|
|
2016
Q1 | $2.07M | Sell |
52,450
-900
| -2% | -$35.6K | 0.6% | 56 |
|
|
2015
Q4 | $3.02M | Hold |
53,350
| – | – | 0.71% | 52 |
|
|
2015
Q3 | $2.12M | Sell |
53,350
-4,000
| -7% | -$159K | 0.5% | 58 |
|
|
2015
Q2 | $2.74M | Sell |
57,350
-1,000
| -2% | -$47.8K | 0.57% | 58 |
|
|
2015
Q1 | $2.32M | Sell |
58,350
-3,000
| -5% | -$119K | 0.46% | 67 |
|
|
2014
Q4 | $1.37M | Sell |
61,350
-200
| -0.3% | -$4.47K | 0.28% | 69 |
|
|
2014
Q3 | $964K | Sell |
61,550
-2,400
| -4% | -$37.6K | 0.21% | 69 |
|
|
2014
Q2 | $949K | Sell |
63,950
-1,700
| -3% | -$25.2K | 0.21% | 64 |
|
|
2014
Q1 | $1.06M | Buy |
65,650
+24,300
| +59% | +$391K | 0.25% | 66 |
|
|
2013
Q4 | $386K | Sell |
41,350
-7,400
| -15% | -$69.1K | 0.09% | 84 |
|
|
2013
Q3 | $552K | Buy |
+48,750
| New | +$552K | 0.15% | 70 |
|